• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼睑复发性基底细胞癌的临床病理分析

Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid.

作者信息

Iljin Aleksandra, Zieliński Tomasz, Antoszewski Bogusław, Sporny Stanisław

机构信息

Department of Plastic, Reconstructive and Aesthetic Surgery, Institute of Surgery, Medical University of Lodz, Lodz, Poland.

Department of Dental Pathology, Medical University of Lodz, Lodz, Poland.

出版信息

Postepy Dermatol Alergol. 2016 Feb;33(1):42-6. doi: 10.5114/pdia.2015.48039. Epub 2016 Feb 29.

DOI:10.5114/pdia.2015.48039
PMID:26985178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4793053/
Abstract

INTRODUCTION

Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions.

AIM

Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures.

MATERIAL AND METHODS

We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000-2012.

RESULTS

In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%.

CONCLUSIONS

Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method.

摘要

引言

基底细胞癌(BCC)是眼睑及周围结构最常见的恶性肿瘤,通常发生在下睑和内眦区域。侵袭性BCC具有较高的复发风险,这往往是由于这些病变切除不完全所致。

目的

对眼睑及周围结构复发性BCC进行临床和病理分析。

材料与方法

我们对2000年至2012年因眼睑复发性BCC接受手术的19例患者(11例女性,8例男性)进行了临床和病理分析,包括对Ki-67抗原的免疫组化反应。

结果

大多数情况下,复发发生在下睑和内眦。15例患者的组织病理学类型未发生变化,4例转变为更具侵袭性的形式。原发性BCC的Ki-67指数值在1%至20%之间,而复发性病变的Ki-67指数值在11%至48%之间。

结论

为确定眼睑及周围结构BCC的复发风险,进行适当的临床和病理评估应包括对预后因素的分析,特别是位置和大小、组织病理学类型以及原发性BCC手术治疗的彻底性。对眼睑及周围结构复发性BCC患者的临床和病理分析应结合增殖指数Ki-67的评估,这对预后和选择合适的治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa7/4793053/c2c8b330d1d8/PDIA-33-24289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa7/4793053/c2c8b330d1d8/PDIA-33-24289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa7/4793053/c2c8b330d1d8/PDIA-33-24289-g001.jpg

相似文献

1
Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid.眼睑复发性基底细胞癌的临床病理分析
Postepy Dermatol Alergol. 2016 Feb;33(1):42-6. doi: 10.5114/pdia.2015.48039. Epub 2016 Feb 29.
2
Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.复发性基底细胞癌:一项关于原发性和复发性病变组织形态学发现的临床病理研究及评估
Acta Dermatovenerol Alp Pannonica Adriat. 2011 Jun;20(2):67-75.
3
Histological and clinical features of primary and recurrent periocular Basal cell carcinoma.原发性和复发性眼周基底细胞癌的组织学和临床特征。
ISRN Ophthalmol. 2012 Apr 24;2012:354829. doi: 10.5402/2012/354829. eCollection 2012.
4
Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited.眼睑区域基底细胞癌手术切除后的长期结果:再探讨。
Wien Klin Wochenschr. 2025 Jan;137(1-2):7-12. doi: 10.1007/s00508-024-02333-5. Epub 2024 Feb 13.
5
Management of periocular basal and squamous cell carcinoma: a series of 485 cases.眼周基底细胞癌和鳞状细胞癌的治疗:485例病例系列
Am J Ophthalmol. 2006 Aug;142(2):293-7. doi: 10.1016/j.ajo.2006.03.055.
6
Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.Mohs 显微外科手术治疗头颈部基底细胞癌的低复发率:1021 例回顾性研究。
Clin Otolaryngol. 2018 Oct;43(5):1321-1327. doi: 10.1111/coa.13176. Epub 2018 Jul 19.
7
Clinical Characteristics of Local Recurrent Basal Cell Carcinoma After Surgical Excision: A Retrospective Study of the Patients From a Tertiary Clinical Center.手术切除后局部复发性基底细胞癌的临床特征:来自三级临床中心患者的回顾性研究
Cureus. 2024 Aug 12;16(8):e66668. doi: 10.7759/cureus.66668. eCollection 2024 Aug.
8
The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.澳大利亚莫氏手术数据库,第一部分:7年眼周基底细胞癌治疗经验
Ophthalmology. 2004 Apr;111(4):624-30. doi: 10.1016/j.ophtha.2003.12.003.
9
Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.沙特阿拉伯眼睑基底细胞癌的特征及相关因素
Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):96-102. doi: 10.4103/meajo.MEAJO_305_17.
10
The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.澳大利亚莫氏手术数据库,第二部分:眼周基底细胞癌5年随访结果。
Ophthalmology. 2004 Apr;111(4):631-6. doi: 10.1016/j.ophtha.2003.11.004.

引用本文的文献

1
Basal Cell Carcinoma of the Right Lower Eyelid Treated With Tarsoconjunctival and Mustardé Flaps.采用睑板结膜瓣和Mustardé皮瓣治疗右下睑基底细胞癌
Cureus. 2025 Feb 16;17(2):e79129. doi: 10.7759/cureus.79129. eCollection 2025 Feb.
2
The free bilamellar autograft (FBA) procedure: A comprehensive case series of an alternative surgical approach to reconstruction of large eyelid defects.游离双层自体移植术(FBA):用于重建大眼睑缺损的另一种手术方法的综合病例系列。
Front Surg. 2023 Feb 24;10:1038952. doi: 10.3389/fsurg.2023.1038952. eCollection 2023.
3
Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland.

本文引用的文献

1
Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma.头颈部基底细胞癌治疗后选定复发风险因素的分析。
Postepy Dermatol Alergol. 2014 Jun;31(3):146-51. doi: 10.5114/pdia.2014.40959. Epub 2014 Jun 13.
2
[Surgical treatment of malignant eyelid tumors].[恶性眼睑肿瘤的外科治疗]
Pol Merkur Lekarski. 2013 Apr;34(202):214-8.
3
Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.复发性基底细胞癌:一项关于原发性和复发性病变组织形态学发现的临床病理研究及评估
原发性和复发性基底细胞癌的临床及组织病理学特征:对波兰北部一家三级临床中心患者的回顾性研究
Postepy Dermatol Alergol. 2022 Feb;39(1):126-131. doi: 10.5114/ada.2022.113806. Epub 2022 Feb 28.
4
Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases.眼睑恶性肿瘤的临床病理分析及手术结果:332例研究
J Skin Cancer. 2022 Feb 18;2022:4075668. doi: 10.1155/2022/4075668. eCollection 2022.
5
Periocular basal cell carcinoma: recurrence risk factors/when to reoperate?眼周基底细胞癌:复发风险因素/何时再次手术?
Postepy Dermatol Alergol. 2020 Dec;37(6):927-931. doi: 10.5114/ada.2020.102109. Epub 2021 Jan 6.
6
A retrospective study of 2228 cases with eyelid tumors.一项对2228例眼睑肿瘤病例的回顾性研究。
Int J Ophthalmol. 2018 Nov 18;11(11):1835-1841. doi: 10.18240/ijo.2018.11.16. eCollection 2018.
7
Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.沙特阿拉伯眼睑基底细胞癌的特征及相关因素
Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):96-102. doi: 10.4103/meajo.MEAJO_305_17.
8
Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?头颈部基底细胞癌(BCC)切除不完全:等待还是不等待?
Postepy Dermatol Alergol. 2017 Dec;34(6):607-611. doi: 10.5114/ada.2017.72467. Epub 2017 Dec 31.
9
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment.眼部基底细胞癌:临床诊断与治疗的简要文献综述
Onco Targets Ther. 2017 May 8;10:2483-2489. doi: 10.2147/OTT.S130371. eCollection 2017.
Acta Dermatovenerol Alp Pannonica Adriat. 2011 Jun;20(2):67-75.
4
Incidence and factors associated with recurrence after incomplete excision of basal cell carcinomas: a study of 90 cases.基底细胞癌不完全切除后复发的发生率及相关因素:90 例研究。
J Eur Acad Dermatol Venereol. 2010 Dec;24(12):1421-4. doi: 10.1111/j.1468-3083.2010.03662.x.
5
Eyelid tumors: histopathological and clinical study performed in County Hospital of Oradea between 2000-2007.眼睑肿瘤:2000年至2007年在奥拉迪亚县医院进行的组织病理学和临床研究。
Rom J Morphol Embryol. 2010;51(1):111-5.
6
Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma.非整倍体而非Ki-67或表皮生长因子受体(EGFR)表达与基底细胞癌复发相关。
J Cutan Pathol. 2008 Oct;35(10):916-21. doi: 10.1111/j.1600-0560.2007.00935.x. Epub 2008 Jun 5.
7
Surgical treatment of basal cell carcinomas using standard postoperative histological assessment.采用标准术后组织学评估的基底细胞癌手术治疗
Australas J Dermatol. 2006 Feb;47(1):1-12. doi: 10.1111/j.1440-0960.2006.00216.x.
8
Basal cell carcinomas of the eyelids.眼睑基底细胞癌
Ophthalmologica. 2005 Mar-Apr;219(2):57-71. doi: 10.1159/000083263.
9
Sebaceous carcinoma of the ocular region: a review.眼部皮脂腺癌:综述
Surv Ophthalmol. 2005 Mar-Apr;50(2):103-22. doi: 10.1016/j.survophthal.2004.12.008.
10
Ki-67 labeling index as a marker of malignancy in ocular surface neoplasms.Ki-67标记指数作为眼表肿瘤恶性程度的标志物
Jpn J Ophthalmol. 2004 Nov-Dec;48(6):524-9. doi: 10.1007/s10384-004-0129-0.